151 related articles for article (PubMed ID: 35846449)
1. Jmjd6 regulates ES cell homeostasis and enhances reprogramming efficiency.
Ji G; Xiao X; Huang M; Wu Q
Heliyon; 2022 Mar; 8(3):e09105. PubMed ID: 35846449
[TBL] [Abstract][Full Text] [Related]
2. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
3. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).
Unoki M; Masuda A; Dohmae N; Arita K; Yoshimatsu M; Iwai Y; Fukui Y; Ueda K; Hamamoto R; Shirakawa M; Sasaki H; Nakamura Y
J Biol Chem; 2013 Mar; 288(9):6053-62. PubMed ID: 23303181
[TBL] [Abstract][Full Text] [Related]
4. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
[TBL] [Abstract][Full Text] [Related]
5. Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells.
Lawrence P; Rieder E
Virus Genes; 2017 Jun; 53(3):340-351. PubMed ID: 28364140
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation.
Hahn P; Wegener I; Burrells A; Böse J; Wolf A; Erck C; Butler D; Schofield CJ; Böttger A; Lengeling A
PLoS One; 2010 Oct; 5(10):e13769. PubMed ID: 21060799
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure of the 2-Oxoglutarate- and Fe(II)-Dependent Lysyl Hydroxylase JMJD6.
Mantri M; Krojer T; Bagg EA; Webby CA; Butler DS; Kochan G; Kavanagh KL; Oppermann U; McDonough MA; Schofield CJ
J Mol Biol; 2010 May; ():. PubMed ID: 20685276
[TBL] [Abstract][Full Text] [Related]
8. Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions.
Kwok J; O'Shea M; Hume DA; Lengeling A
Front Genet; 2017; 8():32. PubMed ID: 28360925
[TBL] [Abstract][Full Text] [Related]
9. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional Enzyme JMJD6 Contributes to Multiple Disease Pathogenesis: New Twist on the Old Story.
Vangimalla SS; Ganesan M; Kharbanda KK; Osna NA
Biomolecules; 2017 Jun; 7(2):. PubMed ID: 28587176
[TBL] [Abstract][Full Text] [Related]
11. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
12. The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.
Wolf A; Mantri M; Heim A; Müller U; Fichter E; Mackeen MM; Schermelleh L; Dadie G; Leonhardt H; Vénien-Bryan C; Kessler BM; Schofield CJ; Böttger A
Biochem J; 2013 Aug; 453(3):357-70. PubMed ID: 23688307
[TBL] [Abstract][Full Text] [Related]
13. Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells.
Shen C; Quan Q; Yang C; Wen Y; Li H
Stem Cell Res Ther; 2018 Aug; 9(1):212. PubMed ID: 30092848
[TBL] [Abstract][Full Text] [Related]
14. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.
Webby CJ; Wolf A; Gromak N; Dreger M; Kramer H; Kessler B; Nielsen ML; Schmitz C; Butler DS; Yates JR; Delahunty CM; Hahn P; Lengeling A; Mann M; Proudfoot NJ; Schofield CJ; Böttger A
Science; 2009 Jul; 325(5936):90-3. PubMed ID: 19574390
[TBL] [Abstract][Full Text] [Related]
15. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
[TBL] [Abstract][Full Text] [Related]
16. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.
Yi J; Shen HF; Qiu JS; Huang MF; Zhang WJ; Ding JC; Zhu XY; Zhou Y; Fu XD; Liu W
Nucleic Acids Res; 2017 Apr; 45(6):3503-3518. PubMed ID: 27899633
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor.
Jablonowski C; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J
bioRxiv; 2023 Nov; ():. PubMed ID: 37425900
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the 2-oxoglutarate- and Fe(II)-dependent lysyl hydroxylase JMJD6.
Mantri M; Krojer T; Bagg EA; Webby CJ; Butler DS; Kochan G; Kavanagh KL; Oppermann U; McDonough MA; Schofield CJ
J Mol Biol; 2010 Aug; 401(2):211-22. PubMed ID: 20684070
[TBL] [Abstract][Full Text] [Related]
19. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
20. PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.
Zhang Z; Jones A; Sun CW; Li C; Chang CW; Joo HY; Dai Q; Mysliwiec MR; Wu LC; Guo Y; Yang W; Liu K; Pawlik KM; Erdjument-Bromage H; Tempst P; Lee Y; Min J; Townes TM; Wang H
Stem Cells; 2011 Feb; 29(2):229-40. PubMed ID: 21732481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
